{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:50:06Z","timestamp":1780516206616,"version":"3.54.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sluggish cognitive tempo (SCT), also referred to as cognitive disengagement syndrome (CDS), is characterized by symptoms such as mental fogginess, slowed behavior, daydreaming, and reduced alertness. It is increasingly recognized as a construct distinct from attention-deficit\/hyperactivity disorder (ADHD). This systematic review and meta-analysis aimed to evaluate the effectiveness of pharmacological interventions on SCT\/CDS-related outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science. Studies assessing pharmacological treatments with reported SCT\/CDS outcomes were included. The primary quantitative synthesis focused on randomized controlled trials and crossover designs, while open-label studies were analyzed qualitatively. Standardized mean differences (Hedges\u2019 g) were calculated using a small-k-robust random-effects model (Paule\u2013Mandel \u03c4\u00b2 estimator with Hartung\u2013Knapp adjustment). A 95% prediction interval was additionally reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of seven studies were included in the qualitative synthesis, of which three (43%) provided sufficient data for meta-analysis. The total sample sizes of individual studies were generally small, contributing to limited statistical power. Using a small-k-robust random-effects model (Paule\u2013Mandel \u03c4\u00b2 with Hartung\u2013Knapp adjustment), the pooled effect was g=0.39 (95% CI: 0.01\u20130.78). The 95% prediction interval was \u22120.06 to 0.85. Between-study heterogeneity ranged from moderate to high (I\u00b2 &amp;gt; 50%), reflecting variability in study design, pharmacological agents, outcome measures, and population characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Preliminary evidence suggests that pharmacological treatments, particularly atomoxetine and methylphenidate, may be associated with moderate improvements in SCT\/CDS symptoms. However, given the limited number of controlled trials and the heterogeneity in populations (e.g., ADHD with comorbid dyslexia), these findings should be considered exploratory. Further large-scale RCTs are necessary to confirm these results and establish personalized treatment protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1787612","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:47:52Z","timestamp":1773298072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Preliminary efficacy of pharmacological treatments on sluggish cognitive tempo (cognitive disengagement syndrome): a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"\u015eenay","family":"K\u0131l\u0131n\u00e7el","sequence":"first","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, School of Medicine, Istanbul Aydin University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"Bulut","sequence":"additional","affiliation":[{"name":"Private Practice, Psychotherapy Instute","place":["Sakarya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"G\u00f6ksel","sequence":"additional","affiliation":[{"name":"Department of Adult Psychiatry, School of Medicine, Ondokuz Mayis University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira\u00e7 Bar\u0131\u015f","family":"Usta","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, School of Medicine, Ondokuz May\u0131s University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O\u011fuzhan","family":"K\u0131l\u0131n\u00e7el","sequence":"additional","affiliation":[{"name":"Department of Child Development, Istanbul Gelisim University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/09297049.2023.2256052","article-title":"Cognitive disengagement syndrome (sluggish cognitive tempo) and medical conditions: a systematic review and call for future research","volume":"30","author":"Fredrick","year":"2023","journal-title":"Child Neuropsychol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10567-022-00411-6","article-title":"Sluggish cognitive tempo (Cognitive disengagement syndrome) and academic functioning: A systematic review and agenda for future research","volume":"26","author":"Fredrick","year":"2022","journal-title":"Clin Child Family Psychol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2022.07.821","article-title":"Report of a work group on sluggish cognitive tempo: key research directions and a consensus change in terminology to cognitive disengagement syndrome","volume":"62","author":"Becker","year":"2023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10862-024-10145-0","article-title":"Cognitive disengagement syndrome (Formerly sluggish cognitive tempo) and comorbid symptoms in child autism, ADHD, and elementary school samples","volume":"46","author":"Mayes","year":"2024","journal-title":"J Psychopathol Behav Assess"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2025.05.006","article-title":"Investigating the shared and divergent neuroanatomical features of attentional deficits in adolescents","author":"Rowe","year":"2025","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21622965.2024.2358239","article-title":"Similarities and differences of neuropsychological functions, metacognitive abilities, and resilience in Cognitive Disengagement Syndrome (CDS) and Attention Deficit\/Hyperactivity Disorder (ADHD)","volume":"15","author":"\u00d6zyurt","year":"2024","journal-title":"Appl Neuropsychol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2015.12.006","article-title":"The internal, external, and diagnostic validity of sluggish cognitive tempo: A meta-analysis and critical review","volume":"55","author":"Becker","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaac.2020.10.016","article-title":"Systematic review: assessment of sluggish cognitive tempo over the past decade","volume":"60","author":"Becker","year":"2021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14145165","article-title":"Cross-sectional and quasi-longitudinal examination of childhood and adult cognitive disengagement syndrome, depression, anxiety, stress, and insomnia","volume":"14","author":"Sadeghi-Bahmani","year":"2025","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1037\/amp0001517","article-title":"Cognitive disengagement syndrome: A construct at the crossroads","volume":"80","author":"Becker","year":"2025","journal-title":"Am Psychol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/10870547241290182","article-title":"Mindful awareness practices (MAPs) in adolescents with ADHD and cognitive disengagement syndrome (CDS): A pilot open trial","volume":"29","author":"Wiggs","year":"2024","journal-title":"J Attention Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40263-023-00999-5","article-title":"Pharmacologic management of cognitive disengagement syndrome (CDS) and implications for attention-deficit\/hyperactivity disorder (ADHD) treatment: emerging treatments and recommendations for future research","volume":"37","author":"Wiggs","year":"2023","journal-title":"CNS Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/cap.2016.0115","article-title":"Atomoxetine-related change in sluggish cognitive tempo is partially independent of change in attention-deficit\/hyperactivity disorder inattentive symptoms","volume":"27","author":"McBurnett","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1087054720902846","article-title":"An open-label trial of methylphenidate treating sluggish cognitive tempo, inattention, and hyperactivity\/impulsivity symptoms among 6- to 12-year-old ADHD children: what are the predictors of treatment response at home and school","volume":"25","author":"F\u0131rat","year":"2020","journal-title":"J Attention Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13687","article-title":"Placebo-controlled trial of lisdexamfetamine in the treatment of comorbid sluggish cognitive tempo and adult ADHD","volume":"82","author":"Adler","year":"2021","journal-title":"J Clin Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5505\/kpd2023.23500","article-title":"Does the coexistence of attention deficit hyperactivity disorder and sluggish cognitive tempo affect the treatment response in children","volume":"26","author":"Yekta\u015f","year":"2023","journal-title":"J Clin Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2013.0054","article-title":"Atomoxetine improved attention in children and adolescents with attention-deficit\/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial","volume":"23","author":"Wietecha","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3592","article-title":"Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report","volume":"9","author":"Tah\u0131ll\u0131o\u011flu","year":"2020","journal-title":"Clin Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/10870547221136216","article-title":"Cognitive performance and psychiatric self-reports across adult cognitive disengagement syndrome and ADHD diagnostic groups","volume":"27","author":"Cerny","year":"2022","journal-title":"J Attention Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/10870547231218945","article-title":"Exploring subfactors of adult cognitive disengagement syndrome and impact on neuropsychological performance","volume":"28","author":"Khalid","year":"2024","journal-title":"J Attention Disord"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2068","article-title":"Assessing the quality of studies in meta-research: review\/guidelines on the most important quality assessment tools","volume":"20","author":"Luchini","year":"2021","journal-title":"Pharm Stat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/00332941241281816","article-title":"Examination of excessive mind-wandering following attention-deficit and hyperactivity disorder treatment in adults","volume":"128","author":"Tak\u0131m","year":"2024","journal-title":"psychol Rep"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1787612\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:47:53Z","timestamp":1773298073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1787612\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":24,"alternative-id":["10.3389\/fpsyt.2026.1787612"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1787612","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"article-number":"1787612"}}